Skip to main content
OpenTrials

Clinical trial condition

Male Urogenital Diseases

Explore clinical trials studying Male Urogenital Diseases. Study availability and eligibility vary by location and protocol.

20,861 public trials 3,480 recruiting studies
Refine in advanced search Browse all conditions

Male Urogenital Diseases trial results

Recruiting

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

NCT06515613

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Endometrial Cancer, +20 more
Locations
  • University of Arkansas Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • SCRI at Denver Health Denver, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

NCT06567743

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, High-Risk Non-Muscle-Invasive Bladder Cancer, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Urology Specialty Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 80 locations
View Trial Details
Recruiting

Polycystic Ovary Syndrome in Type 1 Diabetes

NCT07490964

Conditions
46, XX Disorders of Sex Development, Adnexal Diseases, Adrenogenital Syndrome, +29 more
Locations
  • Department of Endocrinology and Clinical Nutrition, Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo, Km 9.1, 28034-Madrid (Spain) Madrid, Spain
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

Chinese Adults With Kidney Disease

NCT07522099

Conditions
Autoimmune Diseases, Complement 3 Glomerulopathy (C3G), Female Urogenital Diseases, +12 more
Locations
  • ADARx Clinical Site Shenzhen, Guangdong, China
  • ADARx Clinical Site Guiyang, Guizhou, China
  • ADARx Clinical Site Zhengzhou, Henan, China
  • ADARx Clinical Site Baotou, Inner Mongolia, China
View Trial Details
Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

NCT07723248

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Urology Specialists of the Carolinas - University Place Charlotte, North Carolina, United States
  • Summit Urology Murray, Utah, United States
  • First Urology PSC Jeffersonville, Indiana, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
View Trial Details

Related conditions